You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 35.8 KDa. Observed: 32 KDa, reducing conditions
Human
Met1-Trp317
Tag free
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.07 KDa. Observed: 14 KDa, reducing conditions
Human
Met1-Phe136
Tag free
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 26 KDa. Observed: 30 KDa, reducing conditions
Human
Ala2-Ile250
Tag free
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.2 KDa. Observed: 16-18 KDa, reducing conditions
Human
Gly30-Gly154
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (Regularly tested)
Predicted: 16.7 KDa. Observed: 15 KDa, reducing conditions
Mouse
Leu34-Val179
Tag free
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.5 KDa. Observed: 24-35 KDa, reducing conditions
Human
Ala18-Glu144
Tag free
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15 KDa. Observed: 15 KDa, reducing conditions
Human
Arg31-Gln163
Tag free
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.26 KDa. Observed: 16 KDa, reducing conditions
Human
Gly24-Ala155
Tag free
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 9.4 KDa. Observed: 14 KDa, reducing conditions
Human
Ser32-Gln115
Tag free
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.9 KDa. Observed: 20 KDa, reducing conditions
Human
Val30-Met212
Tag free
1 mg, 10 μg, 50 μg, 500 μg